Cargando…

Impact of (18)F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy

High-precision radiotherapy (HPR) of recurrent high grade glioma (HGG) requires accurate spatial allocation of these infiltrative tumors. We investigated the impact of (18)F-FET PET on tumor delineation and progression of recurrent HGG after HPR with carbon ions. T(1) contrast enhanced MRI and (18)F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debus, Charlotte, Waltenberger, Maria, Floca, Ralf, Afshar-Oromieh, Ali, Bougatf, Nina, Adeberg, Sebastian, Heiland, Sabine, Bendszus, Martin, Wick, Wolfgang, Rieken, Stefan, Haberkorn, Uwe, Debus, Jürgen, Knoll, Maximilian, Abdollahi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940831/ https://www.ncbi.nlm.nih.gov/pubmed/29740097 http://dx.doi.org/10.1038/s41598-018-25350-7

Ejemplares similares

Feasibility and robustness of dynamic (18)F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation
por: Debus, Charlotte, et al.
Publicado: (2018)

The impact of tumor metabolic activity assessed by (18)F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients
por: Waltenberger, Maria, et al.
Publicado: (2022)

First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas
por: Dittmar, Jan Oliver, et al.
Publicado: (2017)

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
por: Harrabi, S. B., et al.
Publicado: (2016)

(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy
por: Knoll, Maximilian, et al.
Publicado: (2022)

Performance of [(68)Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients
por: Afshar-Oromieh, Ali, et al.
Publicado: (2021)

Treatment of meningioma and glioma with protons and carbon ions
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review
por: Windisch, Paul, et al.
Publicado: (2020)

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2013)

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy
por: Syed, Mustafa, et al.
Publicado: (2018)

Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
por: Windisch, Paul, et al.
Publicado: (2021)

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
por: Adeberg, Sebastian, et al.
Publicado: (2016)

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2018)

Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patients
por: Röhrich, Manuel, et al.
Publicado: (2020)

Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
por: Afshar-Oromieh, Ali, et al.
Publicado: (2017)

MR Intensity Normalization Methods Impact Sequence Specific Radiomics Prognostic Model Performance in Primary and Recurrent High-Grade Glioma
por: Salome, Patrick, et al.
Publicado: (2023)

Intra-individual comparison of (68)Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer
por: Giesel, F. L., et al.
Publicado: (2016)

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
por: Adeberg, Sebastian, et al.
Publicado: (2018)

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with (131)I-MIP-1095
por: Afshar-Oromieh, Ali, et al.
Publicado: (2017)

Definitive Radiotherapy for Squamous Cell Carcinoma of The Oral Cavity: a Single-institution Experience
por: Lang, Kristin, et al.
Publicado: (2021)

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution
por: Högerle, Benjamin A., et al.
Publicado: (2019)

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2014)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

MITK-ModelFit: A generic open-source framework for model fits and their exploration in medical imaging – design, implementation and application on the example of DCE-MRI
por: Debus, Charlotte, et al.
Publicado: (2019)

modelBuildR: an R package for model building and feature selection with erroneous classifications
por: Knoll, Maximilian, et al.
Publicado: (2021)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity
por: Lang, Kristin, et al.
Publicado: (2018)

Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients
por: Regnery, Sebastian, et al.
Publicado: (2020)

Retrospective analysis of outcome and toxicity after postoperative radiotherapy in patients with squamous cell carcinoma of the lip
por: Lang, Kristin, et al.
Publicado: (2021)

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
por: Combs, Stephanie E, et al.
Publicado: (2011)

Radiation dosimetry and first therapy results with a (124)I/(131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
por: Zechmann, Christian M., et al.
Publicado: (2014)

Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
por: Syed, M., et al.
Publicado: (2020)

FAPI-74 PET/CT Using Either (18)F-AlF or Cold-Kit (68)Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

MR-Class: A Python Tool for Brain MR Image Classification Utilizing One-vs-All DCNNs to Deal with the Open-Set Recognition Problem
por: Salome, Patrick, et al.
Publicado: (2023)

Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy
por: Lang, Kristin, et al.
Publicado: (2020)

T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology
por: Foltyn, Martha, et al.
Publicado: (2020)

DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_thpsbq5ut445qmcfbu8g5k8v41